Skip to content

Press Releases

Every day, more lives are transformed all over the world – one healthy habit at a time. Read the latest about how Medifast and the OPTAVIA® movement is impacting people’s lives.

Medifast's Executives File Form 4; Company's CEO and Director Purchase Common Stock
PRNewswire-FirstCall
OWINGS MILLS, Md.

Medifast, Inc. announced today that its Chairman and Chief Executive Officer Bradley T. MacDonald and outside Director R. Scott Zion each recently purchased 10,000 shares of Medifast's common stock in the open market. The executives have filed Form 4 with the Securities and Exchange Commission. Mr. MacDonald's beneficial ownership is over 1.3 million shares of stock and he remains the single largest shareholder of the company.

This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, outcomes of government inquiries and investigations and related litigation, continued compliance with government regulations, fluctuations in customer demand, management of rapid growth, intensity of competition from other healthcare product companies, timing and acceptance of new product introductions, general economic conditions, geopolitical events and regulatory changes, as well as other especially relevant risks detailed in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the period ended December 31, 2003 and its Quarterly Reports on Form 10-Q for the quarters ended March 31, June 30, September 30, 2003 and March 31, 2004 and its 8-K dated March 23, 2004. The information set forth herein should be read in light of such risks. The Company assumes no obligation to update the information contained in this press release.

SOURCE: Medifast, Inc.

CONTACT: Jeremy Hunt, Investor Relations Specialist, +1-410-504-8196, or
Casey Seward, Public Relations Manager, +1-410-504-8154, both of Medifast,
Inc.; or Ken Sgro, CEOcast, Inc. for Medifast, +1-212-732-4300